Insider Shareholders with Direct Ownership of Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
This section provides a comprehensive overview of the insiders with direct ownership of Shuttle Pharmaceuticals Holdings, Inc. (SHPH). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Shuttle Pharmaceuticals Holdings, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Milton Brown
Director |
0 | 3,916 | 1,094,610 $842,849 | 2 |
Dec 13, 2023
Reduced 0.27%
|
|
Anatoly Dritschilo
CEO and Chairman |
0 | 8,372 | 1,085,200 $835,604 | 1 |
Dec 29, 2022
Reduced 0.77%
|
| 0 | 995 | 184,071 $141,734 | 1 |
Dec 29, 2022
Reduced 0.54%
|
|
|
Mira Jung
Chief Scientific Officer |
0 | 926 | 135,715 $104,500 | 2 |
May 01, 2024
Reduced 0.44%
|
|
Hoek Michael Vander
Chief Financial Officer |
100,000 | 2,243 | 103,852 $79,966 | 2 |
Mar 08, 2024
Added 49.06%
|
|
Bette Jacobs
Director |
0 | 8,523 | 27,064 $20,839 | 2 |
Dec 13, 2023
Reduced 13.31%
|
|
Peter Dritschilo
President and COO |
0 | 3,820 | 6,560 $5,051 | 1 |
Dec 29, 2022
Reduced 36.8%
|
|
Chris Senanayake
Director |
0 | 1,626 | 2,791 $2,149 | 1 |
Dec 29, 2022
Reduced 36.81%
|
|
Tyvin Rich
Chief Medical Officer |
0 | 1,414 | 2,429 $1,870 | 1 |
Dec 29, 2022
Reduced 36.79%
|
|
Steven M Richards
Director |
0 | 995 | 1,707 $1,314 | 1 |
Dec 29, 2022
Reduced 36.82%
|